NCT04773782 2026-01-13A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingBlueprint Medicines CorporationPhase 1/2 Completed29 enrolled
NCT04714086 2024-10-24Expanded Access Program for AvapritinibBlueprint Medicines CorporationNo longer available